Earnings Update: Fine Foods & Pharmaceuticals N.T.M. S.p.A. (BIT:FF) Just Reported Its First-Quarter Results And Analysts Are Updating Their Forecasts
May 11
Have your own idea? Try our Stock Screener
Italian (Borsa Italiana) Life Sciences Industry Analysis
UpdatedMay 19, 2025
DataAggregated Company Financials
Companies1
- 7D1.9%
- 3M11.3%
- 1Y-10.5%
- YTD2.1%
Over the last 7 days, the Life Sciences industry has risen 4.2%, driven by gains from every company within the industry. In contrast, the industry has lost 12% in the last 12 months. As for the next few years, earnings are expected to grow by 24% per annum.
Industry Valuation and Performance
Has the Italian Life Sciences Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Mon, 19 May 2025 | €187.5m | €241.8m | €9.4m | 20x | 20x | 0.8x |
| Wed, 16 Apr 2025 | €171.4m | €244.4m | €8.2m | 21x | 21x | 0.7x |
| Fri, 14 Mar 2025 | €166.0m | €243.4m | €4.9m | 34.2x | 34.2x | 0.7x |
| Sun, 09 Feb 2025 | €167.5m | €243.4m | €4.9m | 34.5x | 34.5x | 0.7x |
| Tue, 07 Jan 2025 | €194.4m | €243.4m | €4.9m | 40.1x | 40.1x | 0.8x |
| Thu, 05 Dec 2024 | €190.0m | €243.4m | €4.9m | 39.2x | 39.2x | 0.8x |
| Sat, 02 Nov 2024 | €204.2m | €247.2m | €2.6m | 78.2x | 78.2x | 0.8x |
| Mon, 30 Sep 2024 | €214.5m | €247.2m | €2.6m | 82.2x | 82.2x | 0.9x |
| Wed, 28 Aug 2024 | €204.7m | €251.8m | -€3,610,645.00 | n/a | -56.7x | 0.8x |
| Fri, 26 Jul 2024 | €213.5m | €251.8m | -€3,610,645.00 | n/a | -59.1x | 0.8x |
| Sun, 23 Jun 2024 | €223.3m | €251.8m | -€3,610,645.00 | n/a | -61.8x | 0.9x |
| Tue, 21 May 2024 | €213.0m | €251.9m | -€3,610,645.00 | n/a | -59x | 0.8x |
| Thu, 18 Apr 2024 | €204.7m | €251.8m | -€3,522,098.00 | n/a | -58.1x | 0.8x |
| Sat, 16 Mar 2024 | €206.6m | €239.7m | €627.8k | 329.2x | 329.2x | 0.9x |
| Mon, 12 Feb 2024 | €218.0m | €239.7m | €627.8k | 347.3x | 347.3x | 0.9x |
| Wed, 10 Jan 2024 | €213.1m | €239.7m | €627.8k | 339.5x | 339.5x | 0.9x |
| Fri, 08 Dec 2023 | €204.3m | €239.7m | €627.8k | 325.5x | 325.5x | 0.9x |
| Sun, 05 Nov 2023 | €186.2m | €233.7m | -€5,128,619.00 | n/a | -36.3x | 0.8x |
| Tue, 03 Oct 2023 | €205.7m | €233.7m | -€5,128,619.00 | n/a | -40.1x | 0.9x |
| Thu, 31 Aug 2023 | €199.6m | €221.7m | -€4,112,756.00 | n/a | -48.5x | 0.9x |
| Sat, 29 Jul 2023 | €196.4m | €221.7m | -€4,112,756.00 | n/a | -47.8x | 0.9x |
| Mon, 26 Jun 2023 | €230.4m | €221.7m | -€4,112,756.00 | n/a | -56x | 1x |
| Wed, 24 May 2023 | €231.5m | €221.7m | -€4,112,756.00 | n/a | -56.3x | 1x |
| Fri, 21 Apr 2023 | €227.0m | €206.9m | -€9,501,145.00 | n/a | -23.9x | 1.1x |
| Sun, 19 Mar 2023 | €233.2m | €202.7m | -€10,427,495.00 | n/a | -22.4x | 1.2x |
| Tue, 14 Feb 2023 | €229.3m | €202.7m | -€10,427,495.00 | n/a | -22x | 1.1x |
| Thu, 12 Jan 2023 | €202.2m | €202.7m | -€10,427,495.00 | n/a | -19.4x | 1x |
| Sat, 10 Dec 2022 | €204.2m | €202.7m | -€10,427,495.00 | n/a | -19.6x | 1x |
| Mon, 07 Nov 2022 | €188.8m | €195.6m | -€995,630.00 | n/a | -189.6x | 1x |
| Wed, 05 Oct 2022 | €196.2m | €195.6m | -€995,630.00 | n/a | -197x | 1x |
| Fri, 02 Sep 2022 | €200.1m | €194.1m | -€5,693,684.00 | n/a | -35.1x | 1x |
| Sun, 31 Jul 2022 | €196.4m | €194.1m | -€5,693,684.00 | n/a | -34.5x | 1x |
| Tue, 28 Jun 2022 | €204.9m | €194.1m | -€5,693,684.00 | n/a | -36x | 1.1x |
| Thu, 26 May 2022 | €217.0m | €194.1m | -€5,693,684.00 | n/a | -38.1x | 1.1x |
Price to Earnings Ratio
-38.1x
Current Industry PE
- There is only one company in the Italian Life Sciences industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
- Total earnings for the Life Sciences industry have gone up over the last three years, and the industry is now profitable. Revenues have grown 7.6% per year.
- This means that more sales are being generated by the industry overall, and subsequently profits are increasing too.
Industry Trends
Which industries have driven the changes within the Italian Healthcare industry?
| IT Market | 2.34% | |
| Healthcare | 0.27% | |
| Life Sciences | 1.86% | |
| Clinical Research and Equipment | 1.86% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| FF Fine Foods & Pharmaceuticals N.T.M | €7.66 | 3.0% +€5.4m | -12.0% | PE20x |